"Dr. Adeyefa is a Board Certified Gastroenterologist servicing Cypress TX and the surrounding areas. Though Dr. Adeyefa enjoys the full scope of Gastroenterology, he has special interest in Colon cancer screening, acid reflux/GERD, diarrhea, constipation, irritable bowel syndrome, Gallbladder Disease, Crohn’s Disease/Ulcerative Colitis, and abdominal pain. At the core of our practice is the importance of patient focused care. Dr. Adeyefa believes quality care should always incorporate patient education, as it is important that his patients understand the process of testing, diagnosing, and treatment options involved with their particular condition."

During the past decade, Allied Digestive Disease Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allied Digestive Disease Center" #1 collaborator was "Cristcot HCA LLC" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Allied Digestive Disease Center" are "Colorectal Cancer" (1 trials), "Ulcerative Colitis" (1 trials) and "Ulcerative Proctitis" (1 trials). Many other conditions were trialed in "Allied Digestive Disease Center" in a lesser frequency.

Most popular intervention types in "Allied Digestive Disease Center" are "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator" (1 trials), "Placebo" (1 trials), "Tilpisertib" (1 trials), "Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator" (1 trials) and "Twice daily placebo suppository administered with Sephure applicator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allied Digestive Disease Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Allied Digestive Disease Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Allied Digestive Disease Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allied Digestive Disease Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".